Wells Fargo’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$81.5K Sell
4,351
-3,633
-46% -$66.3K ﹤0.01% 5594
2026
Q1
$134K Sell
7,984
-15,890
-67% -$299K ﹤0.01% 4941
2025
Q4
$457K Sell
23,874
-50,549
-68% -$927K ﹤0.01% 4559
2025
Q3
$1.29M Buy
74,423
+20,689
+39% +$352K ﹤0.01% 3637
2025
Q2
$988K Buy
53,734
+41,929
+355% +$779K ﹤0.01% 3694
2025
Q1
$244K Buy
11,805
+9,009
+322% +$184K ﹤0.01% 4561
2024
Q4
$52.8K Sell
2,796
-649
-19% -$13.4K ﹤0.01% 5464
2024
Q3
$76.1K Sell
3,445
-322
-9% -$6.89K ﹤0.01% 5171
2024
Q2
$76.8K Sell
3,767
-3,274
-46% -$65.1K ﹤0.01% 5098
2024
Q1
$142K Buy
7,041
+1,608
+30% +$30.9K ﹤0.01% 4684
2023
Q4
$98.4K Sell
5,433
-27,581
-84% -$467K ﹤0.01% 4913
2023
Q3
$561K Sell
33,014
-326,416
-91% -$6.06M ﹤0.01% 3689
2023
Q2
$6.85M Sell
359,430
-17,051
-5% -$321K ﹤0.01% 1897
2023
Q1
$7.06M Sell
376,481
-15,126
-4% -$289K ﹤0.01% 1847
2022
Q4
$7.76M Sell
391,607
-140,595
-26% -$2.77M ﹤0.01% 1727
2022
Q3
$9.64M Sell
532,202
-122,684
-19% -$2.46M ﹤0.01% 1549
2022
Q2
$13.1M Sell
654,886
-61,333
-9% -$1.28M ﹤0.01% 1390
2022
Q1
$15.9M Sell
716,219
-58,087
-8% -$1.3M ﹤0.01% 1473
2021
Q4
$19.9M Sell
774,306
-293
-0% -$7.04K 0.01% 1350
2021
Q3
$17.5M Buy
774,599
+5,018
+0.7% +$121K ﹤0.01% 1758
2021
Q2
$17.8M Sell
769,581
-17,180
-2% -$394K ﹤0.01% 1762
2021
Q1
$17.1M Sell
786,761
-42,524
-5% -$891K ﹤0.01% 1791
2020
Q4
$16.9M Buy
829,285
+8,096
+1% +$155K ﹤0.01% 1678
2020
Q3
$14.9M Sell
821,189
-25,865
-3% -$470K ﹤0.01% 1603
2020
Q2
$15.1M Buy
847,054
+43,718
+5% +$772K ﹤0.01% 1551
2020
Q1
$12.3M Sell
803,336
-14,706
-2% -$259K ﹤0.01% 1534
2019
Q4
$15.6M Buy
818,042
+44,353
+6% +$803K ﹤0.01% 1626
2019
Q3
$13.5M Buy
773,689
+50,918
+7% +$892K ﹤0.01% 1712
2019
Q2
$12.9M Buy
722,771
+133,951
+23% +$2.3M ﹤0.01% 1766
2019
Q1
$10.4M Sell
588,820
-19,490
-3% -$340K ﹤0.01% 1919
2018
Q4
$10.2M Buy
608,310
+57,659
+10% +$1.02M ﹤0.01% 1850
2018
Q3
$10.3M Buy
550,651
+52,215
+10% +$946K ﹤0.01% 2048
2018
Q2
$8.49M Buy
498,436
+34,780
+8% +$583K ﹤0.01% 2204
2018
Q1
$7.64M Buy
463,656
+2,650
+0.6% +$46.3K ﹤0.01% 2247
2017
Q4
$8.08M Sell
461,006
-209,871
-31% -$3.73M ﹤0.01% 2163
2017
Q3
$12.5M Buy
670,877
+67,192
+11% +$1.23M ﹤0.01% 1790
2017
Q2
$11.1M Buy
603,685
+27,533
+5% +$484K ﹤0.01% 1836
2017
Q1
$10M Buy
576,152
+126,947
+28% +$2.16M ﹤0.01% 1883
2016
Q4
$6.97M Buy
449,205
+41,775
+10% +$677K ﹤0.01% 2130
2016
Q3
$7.12M Buy
407,430
+101,507
+33% +$1.76M ﹤0.01% 2002
2016
Q2
$5.09M Buy
305,923
+53,809
+21% +$879K ﹤0.01% 2304
2016
Q1
$4.01M Buy
252,114
+24,898
+11% +$385K ﹤0.01% 2458
2015
Q4
$3.95M Buy
227,216
+25,775
+13% +$443K ﹤0.01% 2495
2015
Q3
$3.28M Buy
201,441
+60,563
+43% +$1.16M ﹤0.01% 2618
2015
Q2
$2.79M Buy
140,878
+56,617
+67% +$1.16M ﹤0.01% 2845
2015
Q1
$1.73M Buy
84,261
+47,269
+128% +$954K ﹤0.01% 3133
2014
Q4
$741K Buy
36,992
+22,632
+158% +$439K ﹤0.01% 3708
2014
Q3
$271K Buy
+14,360
New +$287K ﹤0.01% 4214

Other funds holding THQ

Wells Fargo's THQ Position: Q2 2026 in Review

Wells Fargo reduced its abrdn Healthcare Opportunities Fund (THQ) stake by 46% in Q2 2026, selling an estimated $66.3K and leaving 4,351 shares worth $81.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5594.

Wells Fargo first reported a position in THQ in Q3 2014 and has held it in 48 quarters since. The position peaked at $19.9M in Q4 2021. 97 funds tracked by Wall St. Rank hold THQ as of Q2 2026.

  • Wells Fargo held 4,351 shares of abrdn Healthcare Opportunities Fund worth $81.5K as of Q2 2026.
  • Wells Fargo sold 3,633 abrdn Healthcare Opportunities Fund shares in Q2 2026, an estimated $66.3K.
  • abrdn Healthcare Opportunities Fund made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5594 holding.
  • Wells Fargo first reported a position in abrdn Healthcare Opportunities Fund in Q3 2014 and has held it in 48 quarters since.
  • Wells Fargo's abrdn Healthcare Opportunities Fund position peaked at $19.9M in Q4 2021.
  • 97 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.